Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (2083)	11/3/2000 2:16:38 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 4974

Geeeeeze...... Tom Costello on CNBC was just talking about the "concern" with the biotech sector..... that every other sector on earth (loose paraphrase) had corrected, but not the biotechs. This makes Motley Gruel, Arnhold Barfholder, Oscar Mayer, TheStreet.bomb, and Tom. Why can't some of these "insightful" individuals/organizations pick stocks that are over-valued? As we've discussed, there are MANY over-valued stocks in the sector. However, there are many under-valued stocks too. The rationale for all of these individuals....... "bandwidth stocks went down, so Krispy Kreme must be next!!!" Shame on you CNBC. There is a concerted effort to drive paranoia into the sector.

To: nigel bates who wrote (2083)	11/3/2000 6:45:46 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 4974

a pittance..... Friday November 3, 5:39 pm Eastern Time Press Release IDEC Pharmaceuticals Announces Filing of a Registration Statement for 2,000,000 Shares of Common Stock SAN DIEGO--(BW HealthWire)--Nov. 3, 2000--IDEC Pharmaceuticals Corporation (Nasdaq:IDPH - news) today announced that it filed a registration statement with the Securities and Exchange Commission for a proposed offering of 2,000,000 shares of IDEC's common stock. In addition, IDEC will also grant the underwriters of this offering an option to purchase up to 300,000 additional shares of its common stock to cover over-allotments, if any. The public offering is being underwritten in the United States by Merrill Lynch & Co., Salomon Smith Barney and Banc of America Securities LLC. Internationally, the offering is being underwritten by Merrill Lynch International, Salomon Smith Barney and Bank of America International Limited. (snip)